title: Relationships between the presence of anti-Tat antibody, DNA and RNA viral load.
abstract: The possible relationships between the intensity of humoral response to full length Tat protein, the amount of proviral DNA reservoir in peripheral blood mononuclear cells and RNA viral load were analyzed in plasma samples obtained from a group of HIV-1 seropositive subjects, who never received any antiretroviral therapy. All HIV-1 patients showed detectable levels of serum IgG to full-length Tat by immunoenzymatic assay. We found a higher percentage of HIV-1 seropositive subjects with low levels of antibody in the presence of barely detectable proviral DNA copies (< or =10 copies/1.5x10(5) PBMCs) and a high anti-Tat antibody response accompanied by variable (from >10(1) to > or =10(3) copies/1.5x10(5) PBMCs) levels of DNA load (p=0.011). Moreover, an inverse relationship between anti-Tat antibody titers and HIV-1 RNA viral load was demonstrated HIV-1 seropositive patients. In HIV-1-infected patients, a strong humoral immune response against HIV-1 transactivating Tat protein, able to down-modulate viral replication in peripheral blood, does not seem to inhibit the number of proviral DNA molecules in peripheral blood mononuclear cells. Even though our data strongly confirm the "positive" role of anti-Tat antibody on viral replication, the persistence of significant amount of DNA viral load in peripheral blood mononuclear cells, despite high level of anti Tat antibody, suggests a more cautious approach to HIV-1 Tat-containing vaccines, able to stimulate an immune specific response to transactivating Tat protein sufficient in inhibiting circulating virus, but not completely efficient in decreasing proviral DNA integration.
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Microbiology, University of Bologna, Massarenti, Italy.
authors.forename: M C
authors.initials: MC
authors.lastname: Re
authors.forename: D
authors.initials: D
authors.lastname: Gibellini
authors.forename: G
authors.initials: G
authors.lastname: Furlini
authors.forename: M
authors.initials: M
authors.lastname: Vignoli
authors.forename: F
authors.initials: F
authors.lastname: Vitone
authors.forename: I
authors.initials: I
authors.lastname: Bon
authors.forename: M
authors.initials: M
authors.lastname: La Placa
mesh_terms: D000328:Adult; D004279:DNA, Viral / Q000097:blood; D005260:Female; D015696:Gene Products, tat / Q000276:immunology*; D015483:HIV Antibodies / Q000097:blood* / Q000276:immunology; D006679:HIV Seropositivity / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000821:virology*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification*; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D008297:Male; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load; D054322:tat Gene Products, Human Immunodeficiency Virus
chemical_list: D004279:DNA, Viral; D015696:Gene Products, tat; D015483:HIV Antibodies; D007074:Immunoglobulin G; D012367:RNA, Viral; D054322:tat Gene Products, Human Immunodeficiency Virus